Stockscreener 앱 받기
67.57
0.22%
0.15
시간 외 거래:
67.57
전일 마감가:
$67.42
열려 있는:
$67.45
하루 거래량:
1.40M
Relative Volume:
0.24
시가총액:
$26.35B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
47.30
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
+2.29%
1개월 성능:
+8.06%
6개월 성능:
-20.54%
1년 성능:
-16.14%
1일 변동 폭
$67.00
$67.66
1주일 범위
$66.12
$67.95
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
67.57 | 26.29B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
124.84 | 217.03B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.06 | 142.51B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.22 | 135.66B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.52 | 124.70B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.85 | 50.07B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before December 26, 2025 to Discuss Your RightsDXCM - Finviz
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm - GlobeNewswire Inc.
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DAVENPORT & Co LLC Increases Position in DexCom, Inc. $DXCM - MarketBeat
Class Action Lawsuit Filed: DexCom, Inc. (DXCM)Join by December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investor Alert: Deadline Approaching to Join DexCom, Inc. (DXCM) Class ActionContact Levi & Korsinsky - Stockhouse
Voya Investment Management LLC Sells 186,132,582 Shares of DexCom, Inc. $DXCM - MarketBeat
DXCM ALERT: Securities Fraud Class Action Launched Against DexCom, Inc.December 26, 2025 Deadline - ACCESS Newswire
An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 47% Undervalued - 富途牛牛
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
DexCom, Inc. (DXCM) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 26, 2025 Deadline - Stockhouse
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc.(DXCM) Shareholders - The Malaysian Reserve
Lost Money on DexCom, Inc. (DXCM)? Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. $DXCM Shares Sold by Congress Asset Management Co. - MarketBeat
Dexcom G6 Continuous Glucose Monitoring (CGM) Lawsuit - Drugwatch.com
DexCom, Inc. (DXCM) Announces Leadership Transition with New CEO Appointment - GuruFocus
Dexcom Names Jacob Leach as Incoming Chief Executive - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom Inc Announces CEO Appointment - TradingView — Track All Markets
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Levi & Korsinsky Urges DexCom (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential - Insider Monkey
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Securities Lawsuit Alert: DexCom, Inc. (DXCM) InvestorsContact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
What sentiment indicators say about DexCom Inc. stockQuarterly Profit Review & AI Enhanced Trading Signals - Улправда
December 26, 2025 Deadline Approaching: Join Class Action Against DexCom, Inc. (DXCM)Contact Levi & Korsinsky - Stockhouse
Important December 26, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Securities Fraud Class Action Lawsuit - The Malaysian Reserve
Zevenbergen Capital Investments LLC Purchases 62,098 Shares of DexCom, Inc. $DXCM - MarketBeat
Is DexCom Inc. stock supported by strong cash flowsJuly 2025 Trends & Smart Money Movement Tracker - Улправда
Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations - Nasdaq
Will DexCom Inc. stock sustain high P E ratios2025 Key Lessons & Reliable Entry Point Trade Alerts - ulpravda.ru
DXCM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will DexCom Inc. stock benefit from sector rotationJuly 2025 Snapshot & Low Drawdown Trading Techniques - DonanımHaber
Dexcom (DXCM) Gets a Buy from Canaccord Genuity - The Globe and Mail
Investors who lost money on DexCom, Inc. (DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - Sahm
Levi & Korsinsky Reminds DexCom, Inc. Investors of the - GlobeNewswire
Investors in DexCom (NASDAQ:DXCM) have unfortunately lost 43% over the last three years - Yahoo Finance
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky Before December 26, 2025 to Join Class Action - Stockhouse
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. InvestorsLead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit - NewMediaWire
DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Meme Stocks: What sentiment indicators say about DexCom Inc. stockGap Down & Community Verified Trade Signals - ulpravda.ru
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
0.10%
자본화:
|
볼륨(24시간):